NCT06528444View on ClinicalTrials.gov

Clinical Trial Evaluating the Efficacy and Safety of Dexamethasone Compared to Placebo in Patients With Severe Influenza

PHASE3RecruitingINTERVENTIONAL
Enrollment

42

Participants

Timeline

Start Date

October 1, 2024

Primary Completion Date

October 31, 2028

Study Completion Date

October 31, 2028

Conditions
Influenza
Interventions
DRUG

Grup 1 placebo

placebo 1 capsule (6 mg) /day for 7 days.

DRUG

Grup 2 dexametasona

dexamethasone 1 capsule (6 mg)/day for 7 days

Trial Locations (2)

Unknown

RECRUITING

Hospital General Universitario Dr. Balmis de Alicante (centro coordinador), Alicante

RECRUITING

Hospital General Universitario de Elche, Elche

All Listed Sponsors
lead

Instituto de Investigación Sanitaria y Biomédica de Alicante

NETWORK